|
ZA201503119B
|
|
Methods for iontophoretically treating nausea and migraine
|
|
AU2012261753A1
|
|
Transdermal methods and systems for the delivery of anti-migraine compounds
|
|
US2014135679A1
|
|
Detection of presence and alignment of a therapeutic agent in an iontophoretic drug delivery device
|
|
CA2779096A1
|
|
Methods for treating parkinson's disease
|
|
WO2011046927A1
|
|
Transdermal methods and systems for the delivery of rizatriptan
|
|
CN102573489A
|
|
Methods for iontophoretically treating nausea and migraine
|
|
NZ603398A
|
|
Polyamine enhanced formulations for triptan compound iontophoresis
|
|
US2009318847A1
|
|
Polyamine enhanced formulations for triptan compound iontophoresis
|
|
WO2008130640A1
|
|
Implants for the treatment of psychiatric states
|
|
WO2008106144A2
|
|
Implants for the treatment of psychiatric states
|
|
NZ596498A
|
|
Transdermal methods and systems for the delivery of anti-migraine compounds
|
|
AU2007235232A1
|
|
Implants for the treatment of dopamine associated states
|
